CTOs on the Move


 
When Ginger co-founder and COO, Karan Singh, was young, his mother would brew him ginger tea when she could sense that he was about to get sick. A preventative health remedy that originates from Southeast Asia, the ginger root is commonly used at the first sign of illness, before things get worse. Similar to this approach, the Ginger system takes a preventative approach to mental health, addressing issues before they evolve into greater challenges and providing support anywhere, at any time. By bringing the power of on-demand mental health support to hundreds of thousands of people globally, we continue to ...
  • Number of Employees: 250-1000
  • Annual Revenue: $0-1 Million
  • www.ginger.com
  • 116 New Montgomery St 5th Floor
    San Francisco, CA USA 94105
  • Phone: N/A

Executives

Name Title Contact Details

Funding

Ginger raised $100M on 03/23/2021

Similar Companies

MDI Healthcare Solutions

MDI Healthcare Solutions is a Ponte Vedra, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Community Partners

Community Partners is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Portland, ME. To find more information about Community Partners, please visit www.cpime.org

World Congress

World Congress is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. World Congress is based in Woburn, MA. You can find more information on World Congress at www.worldcongress.com

scPharmaceuticals

scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.

Binax

Binax, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Binax, Inc. is based in Scarborough, ME. You can find more information on Binax, Inc. at www.binax.com